An Open Letter to the Food and Drug Administration and Pharmaceutical Industry Concerning Drug Approval for Children With Inflammatory Bowel DiseaseJeffrey S. Hyams, Eric J. Zückerman, Andrew E. Mulberg et al.|Inflammatory Bowel Diseases|2024Cited by 3
Expediting Drug Development for Pediatric Inflammatory Bowel DiseaseAndrew E. Mulberg, Harland S. Winter, Athos Bousvaros et al.|Journal of Pediatric Gastroenterology and Nutrition|2017Cited by 1